{"id":"W3172139422","doi":"10.1200/jco.2021.39.15_suppl.4002","title":"First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) versus chemo in advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): Expanded efficacy and safety data from CheckMate 649.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Nivolumab; Internal medicine; Randomized controlled trial; Ipilimumab; Cancer; Population; Oncology; Adverse effect; FOLFOX; Clinical endpoint; Gastroenterology; Oxaliplatin; Colorectal cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00156635,0.0004454832,0.002684538,0.0002648394,0.0001120782,0.00004132085,0.0005508367,0.0004835779,0.001012221],"category_scores_gemma":[0.001539098,0.0003935258,0.0003664511,0.0006823224,0.000243882,0.000427457,0.0004135987,0.001625836,0.00001001545],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001339051,"about_ca_system_score_gemma":0.002617809,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008083299,"about_ca_topic_score_gemma":0.003041585,"domain_scores_codex":[0.9945111,0.0002918878,0.002944794,0.0008814133,0.00071072,0.0006600989],"domain_scores_gemma":[0.9947551,0.001609114,0.001897697,0.0007779949,0.0003987015,0.0005613733],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.07815094,0.001825747,0.3725589,0.0001796836,0.00164588,0.003399086,0.0002833646,0.00106271,0.0003213518,0.00001222078,0.006612834,0.5339473],"study_design_scores_gemma":[0.1113838,0.003895744,0.8645616,0.0003169583,0.001037718,0.0001602709,0.0002524422,0.002748236,0.0001940839,0.00004264093,0.01515323,0.000253294],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9704211,0.0113475,0.000636483,0.01223932,0.004411431,0.0005375163,0.00007366193,0.00003883023,0.0002941814],"genre_scores_gemma":[0.9574804,0.03056433,0.005023308,0.002098855,0.003724643,0.00002014451,0.0001442897,0.00006551026,0.0008784847],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.533694,"threshold_uncertainty_score":0.999901,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1266036482069207,"score_gpt":0.4363656036335343,"score_spread":0.3097619554266136,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}